Federal Register / Vol. 62, No. 219 / Thursday, November 13, 1997 / Notices 60909

Dated: October 30, 1997.

Joanne Lanahan,

Director, Health Care Administrative

Sanctions, Office of Investigations, OI.

[FR Doc. 97–29792 Filed 11–12–97; 8:45 am]

BILLING CODE 4150–04–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Proposed Collection; Comment

Request; ‘Test-Retest Study of the

Alcohol Use Disorder and Associated

Disabilities Interview Schedule

(AUDADIS–IV) in a General Population

Sample’

SUMMARY: In compliance with Section

3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, which provides

for an opportunity for public comment

on proposed data collection projects, the

National Institute on Alcohol Abuse and

Alcoholism (NIAAA), National

Institutes of Health (NIH) will publish

periodic summaries of proposed

projects to be submitted to the Office of

Management and Budget (OMB) for

review and approval.

Proposed Collection

The Biometry Branch (BB), Division

of Biometry and Epidemiology (DBE),

NIAAA, intends to conduct the ‘TestRetest Study of the Alcohol Use

Disorder and Associated Disabilities

Interview Schedule (AUDADIS–IV) in a

General Population Sample’ to assess

the test-retest reliability of new sections

of the AUDADIS–IV in a general

population sample. The AUDADIS–IV is

a fully-structured interview designed to

collect information on alcohol and drug

use disorders and their associated

psychiatric and medical conditions. The

NIAAA is authorized by Section 464H

of Title IV of the Public Health Act (42

U.S.C. 285n).

The information proposed for

collection in this study will be used by

the NIAAA to develop and finalize

psychometrically sound measures of

alcohol and drug-related disabilities for

use in major epidemiologic surveys

conducted in the United States.

Currently, there is a great need for more

reliable measurement of alcohol and

drug use disorders and their associated

disabilities in all fields of substance use

research.

The annual burden estimates are as

follows:

Type and number of respondents

Responses

per

respondent

Total

responses Hours Total hours

(First (Test Interviews) 500 .............................................................................................. 1 500 1 500

(Second (Retest) Interviews) 500 ..................................................................................... 1 500 1 500

Total Number of Respondents—500 (per year)

Total Number of Responses—1000 (per year)

Total hours—1000 (per year)

Request for Comments

Comments are invited on: (a) Whether

the proposed collection is necessary,

including whether the information has

practical use; (b) ways to enhance the

clarity, quality, and use of the

information to be collected; (c) the

accuracy of the agency estimate of

burden of the proposed collection; and

(d) ways to minimize the collection

burden of the respondents. Send written

comments to Dr. Bridget Grant,

Biometry Branch, Division of Biometry

and Epidemiology (DBE), NIAAA, NIH,

Willco Bldg., Suite 514, 6000 Executive

Boulevard, Bethesda, Maryland 20892–

7003.

For Further Information

To request more information on the

proposed project or to obtain a copy of

the data collection plans, contact Dr.

Bridget Grant, Biometry Branch,

Division of Biometry and Epidemiology,

NIAAA, Willco Bldg., 6000 Executive

Boulevard, Suite 514, Bethesda,

Maryland 20892–7003, or call non-tollfree number (301) 443–7370.

Comments Due Date

Comments regarding this information

collection are best assured of having

their full effect if received on or before

January 12, 1998.

Dated: November 5, 1997.

Martin K. Trusty,

Executive Officer, NIAAA.

[FR Doc. 97–29841 Filed 11–12–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Government-Owned Inventions;

Availability for Licensing

AGENCY: National Institutes of Health,

HHS.

ACTION: Notice.

SUMMARY: The inventions listed below

are owned by agencies of the U.S.

Government and are available for

licensing in the U.S. in accordance with

35 U.S.C. 207 to achieve expeditious

commercialization of results of

federally-funded research and

development. Foreign patent

applications are filed on selected

inventions to extend market coverage

for U.S. companies and may also be

available for licensing.

ADDRESSES: Licensing information and

copies of the U.S. patent applications

listed below may be obtained by writing

to the indicated licensing contact at the

Office of Technology Transfer, National

Institutes of Health, 6011 Executive

Boulevard, Suite 325, Rockville,

Maryland 20852–3804; telephone: 301/

496–7057; fax: 301/402–0220. A signed

Confidential Disclosure Agreement will

be required to receive copies of the

patent applications.

Identification of the Gene Causing

Familial Mediterranean Fever

D Kastner (NIAMS) et al.

Serial No. 60/056,217 filed 21 Aug. 97

Licensing Contact: Stephen Finley, 301/

496–7056 ext. 215

The invention identifies the gene

(MEFV) encoding the protein (pyrin)

that is associated with familial

Mediterranean fever (FMF). FMF, a

recessive inherited disorder, is

characterized by episodes of fever,

inflammation, and unexplained

arthritis, pleurisy, or abdominal pain.

Pyrin is thought to play a role in

keeping inflammation under control,

whereas mutated forms lead to a

malfunctioning protein and

uncontrolled inflammation. Mutated

forms of MEFV were isolated and

correlated to FMF disease. It is

anticipated that the immediate use of

the pyrin gene and its mutations will be

to aid in the diagnosis of FMF. It may

also prove useful for evaluating FMF as

a possible cause of currently

unexplained fevers or abdominal pain.